3 Biotech Stocks Wall Street Thinks Could Rise 44% or Better | BCRX Message Board Posts


BioCryst Pharmaceuticals Inc.

  BCRX website


  • We have set up a new board (#AdminHowTo) to better assist you with using our service and getting the most out of it.

    To access the board, click the blue link above or, if you are a registered member, you can check the latest message from Admin in your IV Inbox and click the link provided there as well.  

BCRX   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  12778 of 12785  at  10/14/2021 10:50:29 AM  by

frnktofini


3 Biotech Stocks Wall Street Thinks Could Rise 44% or Better

From the MotleyFool 

 
 
  • Analysts following BioCryst think the company's first rare disease drug has potential the stock market hasn't considered yet.
 
BioCryst

BioCryst (NASDAQ:BCRX) shares have already doubled in 2021, and the Wall Street analysts who follow the rare disease drugmaker think it can go a lot higher. The consensus price target for BioCryst at the moment represents a 44% premium.

Shares of BioCryst made a big leap after the FDA approved Orladeyo, the company's first drug, to treat a rare blood condition called hereditary angioedema (HAE) last December. The biotech stock has been holding steady for a few months as investors play wait-and-see regarding the Orladeyo launch.

Sales of Orladeyo in the second quarter came in 161% higher than the previous three-month period to reach an annualized run rate of around $114 million. That's encouraging, but still miles behind the market leader Takhzyro, an injection for HAE from Takeda (NYSE:TAK) that earned approval in 2018.

Global Takhzyro sales grew just 6% year over year to an annualized $916 million during Takeda's most recently reported quarter. Another round of quarterly reports that show Orladeyo pushing Takhzyro out of the top spot could push BioCryst stock much higher.



     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 4  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board


Financial Market Data provided by
.
Loading...